PPH — VanEck Pharmaceutical ETF price, holdings and performance

VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF (NASDAQ: PPH) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
108.63
-1.77-1.60%
OverviewShort InterestFilings
PPHVanEck Pharmaceutical ETF·NASDAQ
108.63-1.60%
TA
Loading chart...
Screen all →
VXUS+0.51%$85.02VUG+2.21%$87.08VTV+0.48%$221.00VO+1.03%$81.78VB+1.52%$299.64VGT+1.76%$115.14VWO+0.53%$59.06SPCK+0.05%$22.09
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y35.19%Total Holdings26Perf Week-0.21%
SponsorVanEckETF TypeTagssectorReturn% 3Y13.35%AUM$941.37MPerf Month2.27%
Fund FamilyBond TypeTags-Return% 5Y10.39%NAV/shPerf Quarter8.39%
Index-Average MaturityTags-Return% 10Y52W High112.73 -3.64%Perf Half Y4.50%
Index WeightingCommodity TypeTags-Return% SI52W Low80.43 35.06%Perf YTD7.01%
Active/PassiveQuant TypeTags-Flows% 1M0.00%Volatility1.26% 1.49%Perf Year28.87%
Dividend TTM2.17 (2.00%)ESG TypeTags-Flows% 3M0.32%ATR (14)2.00Perf 3Y37.06%
Dividend Ex-DateJul 01, 2026Dividend TypeSector/ThemeFlows% YTD1.54%RSI (14)53.17Perf 5Y48.31%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.45Perf 10Y80.95%
Expense0.36%Growth/ValueSMA200.36%Flows% 3YRel Volume0.71Prev Close110.40
Inverse/LeveragedMarket CapSMA502.92%Flows% 5YAvg Volume245.47KPrice108.63
IPO DateDec 20, 2011Option/ShortYes / YesSMA2006.56%52W Range %87%Volume174,168Change-1.60%
Assets Under Management
0200.00M400.00M600.00M800.00M'24MarMayJulSepNov'25MarMayJulSepNov'26MarMayJul
● Assets Under Management
Latest News
Jul-26-26
Jul-26-2601:01PM
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?fool.com
Jul-24-26
Jul-24-2606:25AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?Benzinga
Jul-22-26
Jul-22-2611:53PM
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJfool.com
Jul-20-26
Jul-20-2610:44AM
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?fool.com
Jul-18-26
Jul-18-2601:03PM
AI Bubble Risks Make Dividend Stocks Attractive Againseekingalpha.com
Jul-17-26
Jul-17-2608:50AM
The Next Big Theme: July 2026SeekingAlpha
Jul-10-26
Jul-10-2602:30AM
Healthcare Investing: Finding Growth Beyond PharmaceuticalsSeekingAlpha
Jul-09-26
Jul-09-2608:15AM
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?fool.com
Jul-08-26
Jul-08-2611:01AM
4 ETF Winners of June Likely to Gain in Julyzacks.com
Jul-07-26
Jul-07-2605:25PM
Namib Minerals Announces Board and Executive Leadership Appointments to Support Next Phase of Growthglobenewswire.com
Jul-04-26
Jul-04-2604:11PM
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?fool.com
Jun-29-26
Jun-29-2605:20PM
Biotech Is The Rate Cut Trade In DisguiseSeekingAlpha
05:00PM
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address Itseekingalpha.com
Jun-23-26
Jun-23-2602:50PM
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New OpportunitiesSeekingAlpha
Fund

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR